IRCT20210926052596N1招募中3 期
Comparison of the Effectiveness of Pioglitazone and Clobetasol and their possible adverse effect on patients with Lichen Planopilaris
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 70 years（—）
- 性别
- All
入选标准
- •All patients between 15-70 years old with lichen planopilaris
- •localized disease in which there was no need for systemic immunosuppressors
- •no pregnancy or history of OCP consumption
- •the patient a new case or was a known case who did not receive medication during the las three months
- •no history of consuming a drug interaction with Pioglitazone
- •no contraindication for Pioglitazone consumption such as diabetes mellitus, heart failure, hypersensitivity reaction to Pioglitazone
- •Assign written informed consent
排除标准
- •Unwillingness to participate
- •pioglitazone contraindications (diabetes, heart failure, COPD, kidney or liver disease, diabetes, allergy to pioglitazone)
- •pregnancy or OCP use
- •progressive multifocal disease ( that is a candidate for systemic or immunosuppressive treatment)
- •known case of LPP and a history of drug use in the past three months
- •taking drugs interacting with pioglitazone.
研究者
相似试验
已完成
2 期
Comparison the treatment effect of Pioglithazone with Metformin in patients withNon Alcoholic SteatoHepatitis (NASH)Fatty liver.fatty (change of) liver, not elsewhere classifiedIRCT201105026361N1Vice chancellor for research, Kashan University of Medical Sciences and Health Services80
招募中
3 期
comparison the teraputic effect of pioglitazone and carnitine to metformin and carnitine in patients with non alcoholic fatty liver diseasenon alcoholic fatty liver disease (NAFLD).Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20190701044062N3Tabriz University of Medical Sciences80
招募中
不适用
Comparison of efficacy and safety of pioglitazone versus metformin for moderate-to-severe chronic plaque psoriasis in patients with prediabetes or newly-diagnosed diabetes who have never taken anti-diabetic agents: a parallel, randomized, open-label, prospective studypsoriasisprediabetesdiabetes mellitusplaquepsoriasisprediabetesdiabetes mellitusTCTR20190724005Dermatological Society of Thailand (pending)40
已完成
3 期
comparison the therapeutic effect of pioglitazone and carnitine to pioglitazone and vitamin E in patients with non alcoholic fatty liver diseaseIRCT20190701044062N8Tabriz University of Medical Sciences80
进行中（未招募）
不适用
Comparison of the Effects of Pioglitazone vs. Placebo when given in addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus and Renal Failure – The PIOren Study - PIOren StudyThe study population will consist of insufficiently controlled patients with type 2 diabetes with renal failure requiring dialysisMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2007-006744-21-DETakeda Pharma GmbH